Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors
Open Access
- 8 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Communications Biology
- Vol. 3 (1), 1-14
- https://doi.org/10.1038/s42003-020-0956-7
Abstract
Photodynamic therapy (PDT) ablates malignancies by applying focused near-infrared (nIR) light onto a lesion of interest after systemic administration of a photosensitizer (PS); however, the accumulation of existing PS is not tumor-exclusive. We developed a tumor-localizing strategy for PDT, exploiting the high expression of heat shock protein 90 (Hsp90) in cancer cells to retain high concentrations of PS by tethering a small molecule Hsp90 inhibitor to a PS (verteporfin, VP) to create an Hsp90-targeted PS (HS201). HS201 accumulates to a greater extent than VP in breast cancer cells both in vitro and in vivo, resulting in increased treatment efficacy of HS201-PDT in various human breast cancer xenografts regardless of molecular and clinical subtypes. The therapeutic index achieved with Hsp90-targeted PDT would permit treatment not only of localized tumors, but also more diffusely infiltrating processes such as inflammatory breast cancer.This publication has 50 references indexed in Scilit:
- High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric CancerPLOS ONE, 2013
- Estimation of Citywide Air Pollution in BeijingPLOS ONE, 2013
- A highly selective Hsp90 affinity chromatography resin with a cleavable linkerBioorganic & Medicinal Chemistry, 2012
- Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancersBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Photodynamic therapy enhancement of anti-tumor immunityPhotochemical & Photobiological Sciences, 2011
- Stimulation of anti-tumor immunity by photodynamic therapyExpert Review of Clinical Immunology, 2011
- Imaging Tumor Variation in Response to Photodynamic Therapy in Pancreatic Cancer Xenograft ModelsInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Expression of heat shock protein 90 at the cell surface in human neuroblastoma cellsCell Stress and Chaperones, 2009
- Age-related macular degenerationThe Lancet, 2008
- Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cellsCell Stress and Chaperones, 2008